pioglitazone has been researched along with Arrhythmia in 4 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present investigation was designed to study the cardioprotective effects of nicorandil and pioglitazone preconditioning in myocardial ischemia/reperfusion-induced hemodynamic, biochemical and histological changes in rats." | 7.77 | Pharmacological preconditioning with nicorandil and pioglitazone attenuates myocardial ischemia/reperfusion injury in rats. ( Agha, AM; Ahmed, LA; Attia, AS; Salem, HA, 2011) |
| "pioglitazone) users was 0." | 5.56 | The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety. ( Aquilante, CL; Bilker, WB; Bloomgarden, ZT; Brensinger, CM; Dawwas, GK; Deo, R; Dhopeshwarkar, N; Flory, JH; Gagne, JJ; Hennessy, S; Kimmel, SE; Leonard, CE; Soprano, SE, 2020) |
| "The present investigation was designed to study the cardioprotective effects of nicorandil and pioglitazone preconditioning in myocardial ischemia/reperfusion-induced hemodynamic, biochemical and histological changes in rats." | 3.77 | Pharmacological preconditioning with nicorandil and pioglitazone attenuates myocardial ischemia/reperfusion injury in rats. ( Agha, AM; Ahmed, LA; Attia, AS; Salem, HA, 2011) |
| "We investigated the effects of ischemic preconditioning (IP) on reperfusion arrhythmias in type 2 diabetic rats as well as the effects of the insulin sensitizer pioglitazone." | 3.74 | The insulin sensitizer pioglitazone improves the deterioration of ischemic preconditioning in type 2 diabetes mellitus rats. ( Kawai, M; Mochizuki, S; Mori, C; Ogawa, K; Okazaki, F; Sasaki, H; Shimizu, M; Takatsuka, H; Taniguchi, I, 2007) |
| "pioglitazone) users was 0." | 1.56 | The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety. ( Aquilante, CL; Bilker, WB; Bloomgarden, ZT; Brensinger, CM; Dawwas, GK; Deo, R; Dhopeshwarkar, N; Flory, JH; Gagne, JJ; Hennessy, S; Kimmel, SE; Leonard, CE; Soprano, SE, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leonard, CE | 1 |
| Brensinger, CM | 1 |
| Dawwas, GK | 1 |
| Deo, R | 1 |
| Bilker, WB | 1 |
| Soprano, SE | 1 |
| Dhopeshwarkar, N | 1 |
| Flory, JH | 1 |
| Bloomgarden, ZT | 1 |
| Gagne, JJ | 1 |
| Aquilante, CL | 1 |
| Kimmel, SE | 1 |
| Hennessy, S | 1 |
| García-Beltran, C | 1 |
| Cereijo, R | 1 |
| Quesada-López, T | 1 |
| Malpique, R | 1 |
| López-Bermejo, A | 1 |
| de Zegher, F | 1 |
| Ibáñez, L | 1 |
| Villarroya, F | 1 |
| Ahmed, LA | 1 |
| Salem, HA | 1 |
| Attia, AS | 1 |
| Agha, AM | 1 |
| Sasaki, H | 1 |
| Ogawa, K | 1 |
| Shimizu, M | 1 |
| Mori, C | 1 |
| Takatsuka, H | 1 |
| Okazaki, F | 1 |
| Kawai, M | 1 |
| Taniguchi, I | 1 |
| Mochizuki, S | 1 |
1 trial available for pioglitazone and Arrhythmia
| Article | Year |
|---|---|
Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization.
Topics: Adipocytes; Adipogenesis; Adipose Tissue, Brown; Adolescent; Arrhythmias, Cardiac; Biomarkers; Chemo | 2020 |
3 other studies available for pioglitazone and Arrhythmia
| Article | Year |
|---|---|
The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety.
Topics: Adult; Aged; Arrhythmias, Cardiac; Databases, Factual; Death, Sudden, Cardiac; Diabetes Mellitus, Ty | 2020 |
Pharmacological preconditioning with nicorandil and pioglitazone attenuates myocardial ischemia/reperfusion injury in rats.
Topics: Animals; Arrhythmias, Cardiac; Heart Rate; Ischemic Preconditioning, Myocardial; Male; Myocardial Is | 2011 |
The insulin sensitizer pioglitazone improves the deterioration of ischemic preconditioning in type 2 diabetes mellitus rats.
Topics: Animals; Arrhythmias, Cardiac; Coronary Circulation; Diabetes Mellitus, Type 2; Disease Models, Anim | 2007 |